Stock Taper 
STLN
$6.46
▼ DOWN 1.15% (-0.07)
KEY STATISTICS
Market Cap$646.39 M
52w High$7.05
52w Low$2.32
Dividend Yield—
Frequency—
P/E—
Volume1.53M
Shares Out.99.98M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Daniel Virnich
ABOUT
SECTOR
Healthcare
WENT PUBLIC
August 4, 2026
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
641
PRICE
$6.46 ▼ DOWN 1.15% (−$0.07)About Starling Oncology, Inc.
https://www.starlingoncology.com ↗Starling Oncology, Inc. is a value-based, community-focused oncology platform founded in 2007, providing evidence-based cancer treatments, clinical trials, and transfusions to diverse patients, providers, and health plans.
INDUSTRY
Medical - Care Facilities
A SERVICE STARLING ONCOLOGY, INC. IS KNOWN FOR
Value-Based Cancer Care
Starling Oncology offers specialized, value-based cancer care through treatment centers, clinical trials, and in-house pharmacy, delivering coordinated, evidence-based services to a broad patient population across multiple community clinics.
RATINGS SNAPSHOT
Overall rating: C
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2
INSIDER TRADES
★
10 PERCENT OWNER
Chernett Jorey
Sale · 100 shares
2026-08-13
★
10 PERCENT OWNER
Chernett Jorey
Purchase · 12.0K shares
2026-08-14
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 3
3 GRADES IN THE LAST 12 MONTHS
